InvestorsHub Logo
Followers 6
Posts 333
Boards Moderated 0
Alias Born 02/06/2023

Re: None

Wednesday, 06/07/2023 9:28:19 PM

Wednesday, June 07, 2023 9:28:19 PM

Post# of 427287
Given low volume trading and decades of investing experience, running Amarin into double digits isn't rocket science. I'm being honest here when I think Vascepa may prolong the onset of Alzheimer's based on research I've been doing for a few years. If that were the case, here comes $100/share and honestly that's part of why I hang in here... Just being honest.

I'm inclined per my own research that Vascepa is one of those legacy drugs with more than one major application. I seriously think Alzheimer's is the biggy here and it's why I stay.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News